Dar Aldawa obtained its license for its regional headquarters in the Kingdom of Saudi Arabia

Dar Aldawa Development & Investment Company has announced that it has obtained a regional headquarters license in Saudi Arabia. This step marks a new phase in the company’s efforts to strengthen its presence in the Kingdom and the region, representing a significant development in its successful journey.

The company’s Chief Executive Officer, Mr. Khaled Harb, stated that the establishment of this main operations center, together with the existing centers in Jordan and Algeria, is an important strategic step in the history of the company and that this step is a reinforcement of the ability of Dar Aldawa to serve patients and the medical community in the region and contribute to the transformation of the healthcare sector in accordance with Jordan Vision 2030.

As a pharmaceutical company that owns production plants in both Jordan and Algeria, Dar Aldawa adopts an approach that focuses on the development, production, and marketing high-quality pharmaceutical products. The company markets its products in more than 50 countries in the Middle East, North Africa, and Europe, where more than 900 employees serve patients and meet the needs of the medical community.

Dar Aldawa is a pioneering pharmaceutical company in the Middle East and North Africa with nearly 50 years of experience. It has gained the trust of patients and healthcare professionals and is renowned for its exceptional quality.